Lancet, The, ISSN 0140-6736, 2016, Volume 389, Issue 10071, pp. 861 - 870
Summary Breast and cervical cancers are the commonest cancers diagnosed in women living in low-income and middle-income countries (LMICs), where opportunities...
Internal Medicine | INTERNATIONAL INCIDENCE RATES | MEDICINE, GENERAL & INTERNAL | COST-EFFECTIVENESS | GUIDELINE IMPLEMENTATION | HUMAN-PAPILLOMAVIRUS VACCINATION | LOW-RESOURCE SETTINGS | HPV VACCINE | SELF-COLLECTION | RANDOMIZED CONTROLLED-TRIAL | HEALTH-CARE | SCREENING-PROGRAMS | Women | Vaccination | Oncology, Experimental | Breast cancer | Research | Epidemiology | Organic acids | Prevention | Diagnosis | Acetic acid | Papillomavirus infections | Health aspects | Cervical cancer | Cancer | Human papillomavirus | Immunization | Mammography | Health risk assessment | Womens health | Socioeconomic factors
Internal Medicine | INTERNATIONAL INCIDENCE RATES | MEDICINE, GENERAL & INTERNAL | COST-EFFECTIVENESS | GUIDELINE IMPLEMENTATION | HUMAN-PAPILLOMAVIRUS VACCINATION | LOW-RESOURCE SETTINGS | HPV VACCINE | SELF-COLLECTION | RANDOMIZED CONTROLLED-TRIAL | HEALTH-CARE | SCREENING-PROGRAMS | Women | Vaccination | Oncology, Experimental | Breast cancer | Research | Epidemiology | Organic acids | Prevention | Diagnosis | Acetic acid | Papillomavirus infections | Health aspects | Cervical cancer | Cancer | Human papillomavirus | Immunization | Mammography | Health risk assessment | Womens health | Socioeconomic factors
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10033, pp. 2133 - 2144
Summary Investments in cancer control—prevention, detection, diagnosis, surgery, other treatment, and palliative care—are increasingly needed in low-income and...
Internal Medicine | BREAST-CANCER | MORTALITY | MEDICINE, GENERAL & INTERNAL | UNIVERSAL HEALTH COVERAGE | BEVACIZUMAB | SMOKERS | CERVICAL-CANCER | DEATHS | INDIA | CARE | RESOURCE | Global Health - economics | Neoplasms - therapy | Delivery of Health Care - economics | Neoplasms - economics | Developing Countries - statistics & numerical data | Humans | Global Health - statistics & numerical data | Income | Neoplasms - mortality | Neoplasms - diagnosis | Prevention | Medical policy | Liver | Opioids | Palliative treatment | Medical economics | Cervical cancer | Public health | Cancer | Intervention | Global health | Health economics | Disease control | Mortality | Priorities | Low income groups | Economic models | Narcotics | Palliation | Feasibility studies | Viruses | Breast cancer | Cervix | Public finance | Liver cancer | Tobacco | Human papillomavirus | Surgery | Diagnosis | Children
Internal Medicine | BREAST-CANCER | MORTALITY | MEDICINE, GENERAL & INTERNAL | UNIVERSAL HEALTH COVERAGE | BEVACIZUMAB | SMOKERS | CERVICAL-CANCER | DEATHS | INDIA | CARE | RESOURCE | Global Health - economics | Neoplasms - therapy | Delivery of Health Care - economics | Neoplasms - economics | Developing Countries - statistics & numerical data | Humans | Global Health - statistics & numerical data | Income | Neoplasms - mortality | Neoplasms - diagnosis | Prevention | Medical policy | Liver | Opioids | Palliative treatment | Medical economics | Cervical cancer | Public health | Cancer | Intervention | Global health | Health economics | Disease control | Mortality | Priorities | Low income groups | Economic models | Narcotics | Palliation | Feasibility studies | Viruses | Breast cancer | Cervix | Public finance | Liver cancer | Tobacco | Human papillomavirus | Surgery | Diagnosis | Children
Journal Article
Best Practice & Research: Clinical Obstetrics & Gynaecology, ISSN 1521-6934, 2011, Volume 26, Issue 2, pp. 221 - 232
The need for simple, cost-effective screening approaches for cervical cancer prevention in low-resource countries has led to the evaluation of visual screening...
Obstetrics and Gynecology | single visit approach | cervical cancer screening | mortality | screen-and-treat | early detection | prevention | cervical cancer incidence | VIA | COST-EFFECTIVENESS | TEST-PERFORMANCE | LOW-RESOURCE SETTINGS | RANDOMIZED-TRIAL | ACETIC-ACID | OBSTETRICS & GYNECOLOGY | POOR SETTINGS | PAPANICOLAOU TEST | POOLED ANALYSIS | DEVELOPING-COUNTRIES | Early Detection of Cancer - economics | Cervical Intraepithelial Neoplasia - pathology | Reproducibility of Results | Spastic Paraplegia, Hereditary | Uterine Cervical Neoplasms - diagnosis | Early Detection of Cancer - methods | Iodides | Chorea | Humans | Metabolism, Inborn Errors | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Uterine Cervical Neoplasms - pathology | Acetic Acid - economics | Optic Atrophy | Female | Developing Countries | Prevention | Analysis | Oncology, Experimental | Diagnosis | Research | Acetic acid | Papillomavirus infections | Methods | Cervical cancer | Organic acids | Cancer
Obstetrics and Gynecology | single visit approach | cervical cancer screening | mortality | screen-and-treat | early detection | prevention | cervical cancer incidence | VIA | COST-EFFECTIVENESS | TEST-PERFORMANCE | LOW-RESOURCE SETTINGS | RANDOMIZED-TRIAL | ACETIC-ACID | OBSTETRICS & GYNECOLOGY | POOR SETTINGS | PAPANICOLAOU TEST | POOLED ANALYSIS | DEVELOPING-COUNTRIES | Early Detection of Cancer - economics | Cervical Intraepithelial Neoplasia - pathology | Reproducibility of Results | Spastic Paraplegia, Hereditary | Uterine Cervical Neoplasms - diagnosis | Early Detection of Cancer - methods | Iodides | Chorea | Humans | Metabolism, Inborn Errors | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Uterine Cervical Neoplasms - pathology | Acetic Acid - economics | Optic Atrophy | Female | Developing Countries | Prevention | Analysis | Oncology, Experimental | Diagnosis | Research | Acetic acid | Papillomavirus infections | Methods | Cervical cancer | Organic acids | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 2, pp. 165 - 173
Summary Background Population-based cancer survival data, a key indicator for monitoring progress against cancer, are not widely available from countries in...
Hematology, Oncology and Palliative Medicine | REGISTRIES | ONCOLOGY | PATIENT SURVIVAL | ALTERNATIVE APPROACH | Asia - epidemiology | Central America - epidemiology | Humans | Survival Analysis | Neoplasms - mortality | Registries | Africa South of the Sahara - epidemiology | Medical colleges | Liver cancer | Care and treatment | Oncology, Experimental | Diagnosis | Research | Cancer
Hematology, Oncology and Palliative Medicine | REGISTRIES | ONCOLOGY | PATIENT SURVIVAL | ALTERNATIVE APPROACH | Asia - epidemiology | Central America - epidemiology | Humans | Survival Analysis | Neoplasms - mortality | Registries | Africa South of the Sahara - epidemiology | Medical colleges | Liver cancer | Care and treatment | Oncology, Experimental | Diagnosis | Research | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 1, pp. 67 - 77
Summary Background An increase in worldwide HPV vaccination could be facilitated if fewer than three doses of vaccine are as effective as three doses. We...
Hematology, Oncology and Palliative Medicine | EFFICACY | ONCOLOGY | PARTICLE VACCINE | ADOLESCENTS | CLINICAL-TRIALS | COSTA-RICA VACCINE | TYPE-16 | REACTOGENICITY | YOUNG-WOMEN | HUMAN-PAPILLOMAVIRUS INFECTION | FEWER | Human papillomavirus 18 - immunology | Prospective Studies | Cervix Uteri - virology | Drug Administration Schedule | Vaccine Potency | Humans | Papillomavirus Infections - epidemiology | India - epidemiology | Human papillomavirus 16 - immunology | Antibodies, Viral - blood | Incidence | Dose-Response Relationship, Drug | Early Termination of Clinical Trials | Vaccination - methods | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - administration & dosage | Papillomavirus Infections - prevention & control | Adolescent | Papillomavirus Infections - immunology | Female | Human papillomavirus 11 - immunology | Child | Antibodies, Neutralizing - blood | Prevention | Medical research | Sexually transmitted diseases | Analysis | Vaccination | Medicine, Experimental | Vaccines | Papillomavirus infections
Hematology, Oncology and Palliative Medicine | EFFICACY | ONCOLOGY | PARTICLE VACCINE | ADOLESCENTS | CLINICAL-TRIALS | COSTA-RICA VACCINE | TYPE-16 | REACTOGENICITY | YOUNG-WOMEN | HUMAN-PAPILLOMAVIRUS INFECTION | FEWER | Human papillomavirus 18 - immunology | Prospective Studies | Cervix Uteri - virology | Drug Administration Schedule | Vaccine Potency | Humans | Papillomavirus Infections - epidemiology | India - epidemiology | Human papillomavirus 16 - immunology | Antibodies, Viral - blood | Incidence | Dose-Response Relationship, Drug | Early Termination of Clinical Trials | Vaccination - methods | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - administration & dosage | Papillomavirus Infections - prevention & control | Adolescent | Papillomavirus Infections - immunology | Female | Human papillomavirus 11 - immunology | Child | Antibodies, Neutralizing - blood | Prevention | Medical research | Sexually transmitted diseases | Analysis | Vaccination | Medicine, Experimental | Vaccines | Papillomavirus infections
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 370, Issue 9585, pp. 398 - 406
Summary Background Cervical cancer is the most common cancer among women in developing countries. We assessed the effect of screening using visual inspection...
Internal Medicine | INSPECTION | MEDICINE, GENERAL & INTERNAL | LOW-RESOURCE SETTINGS | PATTERNS | TRENDS | BENEFITS | STRATEGIES | Uterine Cervical Neoplasms - diagnosis | Nurse's Role | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | India - epidemiology | Mass Screening - methods | Incidence | Acetic Acid | Adult | Female | Indicators and Reagents | Registries | Uterine Cervical Neoplasms - mortality | Studies | Womens health | Mortality | Cervical cancer
Internal Medicine | INSPECTION | MEDICINE, GENERAL & INTERNAL | LOW-RESOURCE SETTINGS | PATTERNS | TRENDS | BENEFITS | STRATEGIES | Uterine Cervical Neoplasms - diagnosis | Nurse's Role | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | India - epidemiology | Mass Screening - methods | Incidence | Acetic Acid | Adult | Female | Indicators and Reagents | Registries | Uterine Cervical Neoplasms - mortality | Studies | Womens health | Mortality | Cervical cancer
Journal Article
European Journal of Gastroenterology & Hepatology, ISSN 0954-691X, 08/2011, Volume 23, Issue 8, pp. 633 - 641
The classification of sites in tumors of the oral cavity, oropharynx, pharynx, and hypopharynx varies in the literature. More than 90% of these tumors of the...
alcohol | papilloma virus | erythroleucoplakia | leukoplakia | oral cavity | tobacco | oropharynx | squamous cell carcinoma | PHARYNGEAL CANCER | SOCIOECONOMIC INEQUALITIES | UPPER AERODIGESTIVE TRACT | FAMILY-HISTORY | NECK-CANCER | TOBACCO SMOKING | SQUAMOUS-CELL CARCINOMA | POOLED ANALYSIS | ALCOHOL-DRINKING | GASTROENTEROLOGY & HEPATOLOGY | INTERNATIONAL HEAD | Oropharyngeal Neoplasms - diagnosis | Precancerous Conditions - etiology | Precancerous Conditions - epidemiology | Virus Diseases - epidemiology | Humans | Risk Factors | Male | Mouth Neoplasms - etiology | Virus Diseases - complications | Mouth Neoplasms - epidemiology | Oropharyngeal Neoplasms - epidemiology | Mouth Neoplasms - diagnosis | Tobacco Use Disorder - complications | Precancerous Conditions - diagnosis | Oropharyngeal Neoplasms - etiology | Tobacco Use Disorder - epidemiology | Female | Oropharyngeal Neoplasms - prevention & control | Precancerous Conditions - prevention & control | Mouth Neoplasms - prevention & control | Index Medicus
alcohol | papilloma virus | erythroleucoplakia | leukoplakia | oral cavity | tobacco | oropharynx | squamous cell carcinoma | PHARYNGEAL CANCER | SOCIOECONOMIC INEQUALITIES | UPPER AERODIGESTIVE TRACT | FAMILY-HISTORY | NECK-CANCER | TOBACCO SMOKING | SQUAMOUS-CELL CARCINOMA | POOLED ANALYSIS | ALCOHOL-DRINKING | GASTROENTEROLOGY & HEPATOLOGY | INTERNATIONAL HEAD | Oropharyngeal Neoplasms - diagnosis | Precancerous Conditions - etiology | Precancerous Conditions - epidemiology | Virus Diseases - epidemiology | Humans | Risk Factors | Male | Mouth Neoplasms - etiology | Virus Diseases - complications | Mouth Neoplasms - epidemiology | Oropharyngeal Neoplasms - epidemiology | Mouth Neoplasms - diagnosis | Tobacco Use Disorder - complications | Precancerous Conditions - diagnosis | Oropharyngeal Neoplasms - etiology | Tobacco Use Disorder - epidemiology | Female | Oropharyngeal Neoplasms - prevention & control | Precancerous Conditions - prevention & control | Mouth Neoplasms - prevention & control | Index Medicus
Journal Article
8.
Full Text
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Vaccine, ISSN 0264-410X, 2012, Volume 30, Issue Suppl 5, pp. F88 - F99
Highlights ► In triage of LSIL, methods more specific than general hrHPV DNA tests may be preferred. ► To predict failure of treatment of high-grade cervical...
Allergy and Immunology | Surveillance after treatment | Screening | ASC-US | Treatment | LSIL | Systematic review | Triage | Diagnostic test accuracy | Cervical cancer | HPV | Meta-analysis | Asc-us | Lsil | Hpv | MEDICINE, RESEARCH & EXPERIMENTAL | METAANALYSIS | PERFORMANCE | HYBRID CAPTURE 2 | RISK | RANDOMIZED CONTROLLED-TRIAL | IMMUNOLOGY | INTRAEPITHELIAL NEOPLASIA | CONVENTIONAL CYTOLOGY | LIQUID-BASED CYTOLOGY | WOMEN | HPV-DNA TEST | Molecular Diagnostic Techniques - methods | Early Detection of Cancer - methods | Papillomavirus Infections - prevention & control | Humans | Uterine Cervical Neoplasms - prevention & control | Female | Secondary Prevention - methods | Virology - methods | Papillomavirus Infections - diagnosis | Papillomavirus Infections - therapy | Oncology, Experimental | Research | Prevention | Analysis | DNA | Medical tests | Universities and colleges | Diagnosis | Papillomavirus infections | Health aspects | Public health | Cancer
Allergy and Immunology | Surveillance after treatment | Screening | ASC-US | Treatment | LSIL | Systematic review | Triage | Diagnostic test accuracy | Cervical cancer | HPV | Meta-analysis | Asc-us | Lsil | Hpv | MEDICINE, RESEARCH & EXPERIMENTAL | METAANALYSIS | PERFORMANCE | HYBRID CAPTURE 2 | RISK | RANDOMIZED CONTROLLED-TRIAL | IMMUNOLOGY | INTRAEPITHELIAL NEOPLASIA | CONVENTIONAL CYTOLOGY | LIQUID-BASED CYTOLOGY | WOMEN | HPV-DNA TEST | Molecular Diagnostic Techniques - methods | Early Detection of Cancer - methods | Papillomavirus Infections - prevention & control | Humans | Uterine Cervical Neoplasms - prevention & control | Female | Secondary Prevention - methods | Virology - methods | Papillomavirus Infections - diagnosis | Papillomavirus Infections - therapy | Oncology, Experimental | Research | Prevention | Analysis | DNA | Medical tests | Universities and colleges | Diagnosis | Papillomavirus infections | Health aspects | Public health | Cancer
Journal Article
Cancer Causes & Control, ISSN 0957-5243, 12/2016, Volume 27, Issue 12, pp. 1437 - 1446
Since most human papilloma virus (HPV) infections regress without any intervention, HPV is a necessary but may not be a solely sufficient cause of cervical...
Biomedicine, general | Public Health | Biomedicine | Hematology | Cervical intraepithelial neoplasia | Cancer Research | Oncology | Invasive cervical cancer | Epidemiology | Risk factors | Sub-Saharan Africa | RISK-FACTORS | COFACTORS | EDUCATION | INDIAN WOMEN | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | HIGH-GRADE | COLOMBIA | ONCOLOGY | DISEASE | CANCER-RISK | COHORT | HUMAN-PAPILLOMAVIRUS INFECTION | Cervical Intraepithelial Neoplasia - pathology | Prevalence | Cross-Sectional Studies | Early Detection of Cancer | Humans | Middle Aged | Papillomavirus Infections - epidemiology | Risk Factors | Uterine Cervical Neoplasms - epidemiology | Uterine Cervical Neoplasms - pathology | Papillomaviridae - isolation & purification | Disease Progression | Cervical Intraepithelial Neoplasia - virology | Papillomavirus Infections - pathology | Pregnancy | Uterine Cervical Neoplasms - virology | Adult | Female | Papillomavirus Infections - virology | Cervical Intraepithelial Neoplasia - epidemiology | Africa South of the Sahara - epidemiology | Parity | Research | Demographic aspects | Cervical cancer
Biomedicine, general | Public Health | Biomedicine | Hematology | Cervical intraepithelial neoplasia | Cancer Research | Oncology | Invasive cervical cancer | Epidemiology | Risk factors | Sub-Saharan Africa | RISK-FACTORS | COFACTORS | EDUCATION | INDIAN WOMEN | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | HIGH-GRADE | COLOMBIA | ONCOLOGY | DISEASE | CANCER-RISK | COHORT | HUMAN-PAPILLOMAVIRUS INFECTION | Cervical Intraepithelial Neoplasia - pathology | Prevalence | Cross-Sectional Studies | Early Detection of Cancer | Humans | Middle Aged | Papillomavirus Infections - epidemiology | Risk Factors | Uterine Cervical Neoplasms - epidemiology | Uterine Cervical Neoplasms - pathology | Papillomaviridae - isolation & purification | Disease Progression | Cervical Intraepithelial Neoplasia - virology | Papillomavirus Infections - pathology | Pregnancy | Uterine Cervical Neoplasms - virology | Adult | Female | Papillomavirus Infections - virology | Cervical Intraepithelial Neoplasia - epidemiology | Africa South of the Sahara - epidemiology | Parity | Research | Demographic aspects | Cervical cancer
Journal Article
Vaccine, ISSN 0264-410X, 2013, Volume 31, Issue Suppl 7, pp. I1 - I31
Highlights • HPV is globally prevalent and related to at least 6 different cancer sites in women and men • Prevention of HPV infections and its consequences is...
Allergy and Immunology | Prevention | Screening | HPV testing | Penile cancer | HPV vaccination | Anal cancer | Oropharyngeal cancer | Vulvar cancer | Cervical cancer | HPV | Vaginal cancer | MEDICINE, RESEARCH & EXPERIMENTAL | COUNTRIES | CERVICAL-CANCER | IMMUNOLOGY | WORLD | VACCINES | Early Detection of Cancer - methods | Humans | Uterine Cervical Neoplasms - epidemiology | Anus Neoplasms - prevention & control | Male | Papillomavirus Infections - diagnosis | Penile Neoplasms - epidemiology | Female | Anus Neoplasms - epidemiology | Papillomavirus Vaccines - administration & dosage | Penile Neoplasms - etiology | Papillomavirus Infections - complications | Global Health | Penile Neoplasms - prevention & control | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Oropharyngeal Neoplasms - epidemiology | Papillomavirus Infections - prevention & control | Oropharyngeal Neoplasms - etiology | Vulvar Neoplasms - prevention & control | Vulvar Neoplasms - epidemiology | Uterine Cervical Neoplasms - etiology | Vulvar Neoplasms - etiology | Oropharyngeal Neoplasms - prevention & control | Papillomavirus Vaccines - immunology | Anus Neoplasms - etiology | Papillomavirus infections | Disease prevention | Human papillomavirus | Teenagers | Vaccines | Womens health
Allergy and Immunology | Prevention | Screening | HPV testing | Penile cancer | HPV vaccination | Anal cancer | Oropharyngeal cancer | Vulvar cancer | Cervical cancer | HPV | Vaginal cancer | MEDICINE, RESEARCH & EXPERIMENTAL | COUNTRIES | CERVICAL-CANCER | IMMUNOLOGY | WORLD | VACCINES | Early Detection of Cancer - methods | Humans | Uterine Cervical Neoplasms - epidemiology | Anus Neoplasms - prevention & control | Male | Papillomavirus Infections - diagnosis | Penile Neoplasms - epidemiology | Female | Anus Neoplasms - epidemiology | Papillomavirus Vaccines - administration & dosage | Penile Neoplasms - etiology | Papillomavirus Infections - complications | Global Health | Penile Neoplasms - prevention & control | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Oropharyngeal Neoplasms - epidemiology | Papillomavirus Infections - prevention & control | Oropharyngeal Neoplasms - etiology | Vulvar Neoplasms - prevention & control | Vulvar Neoplasms - epidemiology | Uterine Cervical Neoplasms - etiology | Vulvar Neoplasms - etiology | Oropharyngeal Neoplasms - prevention & control | Papillomavirus Vaccines - immunology | Anus Neoplasms - etiology | Papillomavirus infections | Disease prevention | Human papillomavirus | Teenagers | Vaccines | Womens health
Journal Article
Community Dentistry and Oral Epidemiology, ISSN 0301-5661, 08/2009, Volume 37, Issue 4, pp. 342 - 349
– Objective: The aim of the study was to evaluate the role of alcohol drinking and patterns of consumption in oral cancer incidence and mortality in a cohort...
alcohol intake | mortality | incidence
alcohol intake | mortality | incidence